 Connection
Paul Bunn to HLA Antigens
This is a "connection" page, showing publications Paul Bunn has written about HLA Antigens.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.143 |
|
|
|
-
Doyle A, Martin WJ, Funa K, Gazdar A, Carney D, Martin SE, Linnoila I, Cuttitta F, Mulshine J, Bunn P, et al. Markedly decreased expression of class I histocompatibility antigens, protein, and mRNA in human small-cell lung cancer. J Exp Med. 1985 May 01; 161(5):1135-51.
Score: 0.057
-
Rosen ST, Radvany R, Roenigk H, Terasaki PI, Bunn PA. Human leukocyte antigens in cutaneous T cell lymphoma. J Am Acad Dermatol. 1985 Mar; 12(3):531-4.
Score: 0.056
-
Beck LK, Kane MA, Bunn PA. Innovative and future approaches to small cell lung cancer treatment. Semin Oncol. 1988 Jun; 15(3):300-14.
Score: 0.018
-
Mitsuya H, Matis LA, Megson M, Bunn PA, Murray C, Mann DL, Gallo RC, Broder S. Generation of an HLA-restricted cytotoxic T cell line reactive against cultured tumor cells from a patient infected with human T cell leukemia/lymphoma virus. J Exp Med. 1983 Sep 01; 158(3):994-9.
Score: 0.013
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|